| CAS: | 119474-55-4 | |||
| 分子式: | C18H17ClFN3O4S | |||
| 分子量: | 425.86 | |||
| 英文名称: |
| |||
| 用途: | KB-5246 是一种四环喹诺酮,具有抗菌活性。 |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||
| K884085 | MACKLIN | KB-5246 | 98% | 13004元/1mg; 20815元/5mg; | 咨询 | ||
储存:2-8℃ | |||||||
| HY-19081 | MCE | KB-5246,119474-55-4_MCE(MedChemExpress) | 咨询 | ||||
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。 KB-5246MCE 国际站:KB-5246 品牌:MedChemExpress (MCE) 货号:HY-19081 CAS 号:119474-55-4 生物活性: KB-5246 是一种四环喹诺酮类化合物,具有抗菌活性。 体外研究(In Vitro):KB-5246 is a tetracyclic quinolone and displays antibacterial activities. The MICs for 90% of isolates tested (MIC90s) of KB-5246 against gram-positive microorganisms such as Staphylococcus aureus, including methicillin-resistant S. aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, and Streptococcus pyogenes, are 0.39 μg/mL. KB5246 inhibits 90% of isolates of Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca at a concentration of 0.10 μg/mL or less. When a concentration of KB-5246 at the MIC or higher is added, no regrowth after 24 h of incubation is observed[1]. MCE尚未独立确认这些方法的准确性。 仅供参考。 体内研究(In Vivo):The 50% effective dose values of KB-5246 against S. pneumoniae 2132 infections are 50.5 mg/kg of body weight. The activities of KB-5246 against S. aureus Smith, P. aeruginosa GN11189, and Serratia marcescens GN7577 infections are comparable to those of ofloxacin and greater than those of norfloxacin[1]. MCE尚未独立确认这些方法的准确性。 仅供参考。 分子量:425.86 Formula:C18H17ClFN3O4S 运输条件:美国大陆地区的室温;其他地区可能有所不同。 储存方式:请按照分析证书中推荐的条件储存产品。 Cell Assay [1]:通过评估KB-5246处理24小时后活菌数量的减少情况来测试其杀菌活性。将敏感性测试肉汤中过夜培养的微生物稀释至约10⁴ CFU/mL,并在相同培养基中于37℃摇床上培养。培养2小时后,向培养物中加入KB-5246,使其最终浓度分别为MIC[1]的一半、一倍、两倍或四倍。MCE尚未独立确认这些方法的准确性。仅供参考。 Animal Administration [1]:In vivo antibacterial activity against systemic infections in mice is determined. Ten male ddY mice weighing 19 to 23 g each are used for each dose level. An overnight culture in brain heart infusion broth at 37°C is diluted appropriately in the same medium with 4% gastrin mucin. A 0.2 mL sample of a bacterial suspension, corresponding to a dose 1 to 25 times higher than the minimal lethal dose, is injected intraperitoneally. Immediately after infection, mice are treated orally with a single dose of KB-5246. The number of mice surviving at each dose is counted 7 days after infection. The 50% effective dose is calculated by the probit method[1]. MCE尚未独立确认这些方法的准确性。 仅供参考。 提供质量检测报告:Data Sheet、产品使用指南 产品活性:KB-5246 是一种四环喹诺酮,具有抗菌活性。 IC50 & Target:Quinolone 相关产品:Anisomycin | Anisomycin (Standard) | BoNT-IN-1 | Sulfaclozine sodium | Rolitetracycline | Berberine chloride | Rolitetracycline (Standard) | Sulfaclozine | Berberine chloride (Standard) | DZ2002 | Walrycin B (Standard) | Baquiloprim 热门产品线:抑制剂 | 稳定性同位素标记物 | 脂质 | 糖类 Trending products:Inhibitors | Isotope-Labeled Compounds | Lipids | Saccharides MCE 抑制剂: MedChemExpress 信号通路产品覆盖细胞凋亡、自噬、细胞周期与 DNA 损伤、表观遗传、GPCR/G 蛋白、免疫与炎症、JAK/STAT、MAPK/ERK、膜转运体与离子通道、代谢酶与蛋白酶、神经信号、NF-κB、PI3K/Akt/mTOR、PROTAC、蛋白酪氨酸激酶/受体酪氨酸激酶、干细胞/Wnt、TGF-β/Smad 及维生素 D/核受体等研究方向,为肿瘤、感染、炎症与免疫、神经系统疾病、代谢性疾病、心血管疾病和内分泌研究提供多维度的产品选择,助力客户发表文献超 80,000 篇。 相关产品可根据具体情况提供化学结构、作用靶点、生物活性、纯度、溶解度、体内外研究信息、参考文献及质量分析报告 (COA)等资料。 客户发表文献: 参考文献: 品牌介绍:
| |||||||